comprehensive -WSS

comprehensive

author：hotspot 2025-10-02 05:38:39 - browse：47775

Janet Woodcock -- health policy coverage from STAT — Janet Woodcock, the FDA's principal deputy commissioner Chip Somodevilla/Getty Images

WASHINGTON — It’s the end of an era for the Food and Drug Administration’s longtime drug chief, but she’s drawn the battle plans for the agency’s next chapter.

Janet Woodcock joined the FDA’s biologics division in 1986 but soon moved to the drug side, where over nearly three decades, she oversaw hundreds of reviews, new and evolving classes of therapies and several clashes with Congress and patient advocates. In recent years, she also warded off attacks on the agency’s decisionmaking during the Covid-19 pandemic, particularly when the agency veteran took the acting commissioner role during President Biden’s long search for a permanent leader, and took charge of a vast reorganization plan sparked by the baby formula crisis.

Some of those efforts still hang in the balance as she departs this week. Critics argue that under her oversight, the drug division worked too closely with pharmaceutical companies to give broad approvals to new medicines like Biogen’s Aduhelm or so-called accelerated approval to controversial therapies like Sarepta’s Duchenne muscular dystrophy medicine Exondys 51, which is still in the midst of post-marketing studies to prove its effectiveness.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： PrEP can help anyone prevent HIV. Why do so few people take it?

WSS

The woman behind the Dana Farber

Sophia Smith scores twice for US in in 3

Statins reduce cardiovascular risk in people living with HIV

SCOTUS to consider access to abortion pill mifepristone

AI models in health care face new federal disclosure requirements

FAMU bans football players from facility after release of rap video shot in team's locker room

hotspot

comprehensive

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

Pregnancy discrimination could be enabled by AI

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Spinal cord stimulation reduces pain in amputees, study finds

Activists slam private health insurers over coverage restrictions

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Drug repurposing or repositioning? The language matters

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

Bright Health sells Medicare Advantage business to Molina

FDA approves first blood sugar monitor without finger pricks

explore

Roche to buy Carmot Therapeutics, developer of obesity drugs

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

After sickle

Clinic falsely told dozens they had Alzheimer's, suits say

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

What Henrietta Lacks's story taught me about my role as a doctor

leisure time

focus

focus

hotspot